Alpha Tau Medical
DRTS
23 hedge funds and large institutions have $2.23M invested in Alpha Tau Medical in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0.5% less ownership
Funds ownership: 1.86% → 1.36% (-0.5%)
4% less funds holding
Funds holding: 24 → 23 (-1)
32% less capital invested
Capital invested by funds: $3.25M → $2.23M (-$1.02M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$59.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$36.1K |
| 3 |
Renaissance Technologies
New York
|
+$31.4K |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$24.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Corbin Capital Partners
New York
|
-$246K |
| 2 |
CG
Caprock Group
Boise,
Idaho
|
-$59K |
| 3 |
Mariner
Overland Park,
Kansas
|
-$2.53K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$832 |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$61 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$61 | -24 | Closed |
|
DRTS Hedge Fund Activity: Q3 2024 in Review
23 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q3 2024, worth a combined $2.23M — down 32% from $3.25M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRTS positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $59.5K. The largest seller was Corbin Capital Partners, exiting entirely with an estimated $246K sold.
- 23 institutional investors held Alpha Tau Medical (DRTS) as of Q3 2024, down from 24 in Q2 2024.
- Funds reported $2.23M of Alpha Tau Medical stock for Q3 2024, down 32% quarter-over-quarter.
- 4 funds opened new Alpha Tau Medical positions in Q3 2024 and 3 closed out, a net change of +1 holder.
- The largest Alpha Tau Medical buyer in Q3 2024 was Levin Capital Strategies, an estimated $59.5K added.
- The largest Alpha Tau Medical seller in Q3 2024 was Corbin Capital Partners, an estimated $246K sold.
Based on aggregated 13F filings for Q3 2024.